Screening Reminders for Barrett's Esophagus
What You Need to Know Before You Apply
What is the purpose of this trial?
Previous studies have shown that screening for Barrett's esophagus (BE), the main risk factor for esophageal adenocarcinoma, is under-utilized in the primary care setting. In fact less than 35% of eligible patients are screened despite endorsement for screening by the major GI societies in patients with risk factors. The purpose of this study is to examine current screening practices and determine if implementation of screening reminders can optimize screening practices for Barrett's Esophagus within a large, academic based healthcare system in NJ.
Who Is on the Research Team?
Arvind Trindade, MD
Principal Investigator
Professor of Medicine
Are You a Good Fit for This Trial?
This trial is for individuals who may be at risk of developing Barrett's Esophagus (BE), a condition that can lead to esophageal cancer. It aims to improve screening rates in a primary care setting within an academic healthcare system in NJ.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of screening reminders for eligible patients to increase BE screening rates
Follow-up
Participants are monitored for BE screening rates and outcomes compared to historical controls
What Are the Treatments Tested in This Trial?
Interventions
- Screening Reminder
Trial Overview
The study is testing whether using screening reminders can increase the number of patients getting screened for BE, compared to current practices without such reminders.
How Is the Trial Designed?
2
Treatment groups
Active Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.